News tagged with novartis
Related topics: food and drug administration
Swiss pharmaceutical giant Novartis said Sunday the expiry of a US patent for its leading hypertension drug Diovan caused a drop in turnover that could last into the first half of 2013.
Medications Oct 07, 2012 | not rated yet | 0
In a special report in The Lancet, researchers from Queen Mary, University of London (UK) argue that pending cases against India's patent laws threaten public health and misinterpret international intellectual property agreem ...
Medications Sep 10, 2012 | not rated yet | 0
Novartis AG and Incyte Corp. said Tuesday that European Union regulators approved their blood cancer drug Jakavi.
Medications Sep 04, 2012 | not rated yet | 0
(HealthDay)—The U.S. Food and Drug Administration has approved Afinitor Disperz (everolimus tablets for oral suspension), the first form of the anti-cancer drug Afinitor to be created especially for children.
Medications Aug 29, 2012 | not rated yet | 0
A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatostatin analogue called pasireotide (SOM230) manufactured by Novartis Pharma ...
Cancer Aug 06, 2012 | not rated yet | 0
(AP) Swiss pharmaceutical company Novartis AG reported a net profit of $2.73 billion during the second quarter, as new drugs and acquisitions offset patent expirations, lower sales of generic medicines ...
Other Jul 19, 2012 | not rated yet | 0
A new set of computer models has successfully predicted negative side effects in hundreds of current drugs, based on the similarity between their chemical structures and those molecules known to cause side effects, according ...
Medical research Jun 11, 2012 | 5 / 5 (2) | 0 |
Greece's highly uncertain future has forced businesses into a quasi hand-to-mouth existence, with one of the most alarming effects a shortage of medicines, including for the seriously ill.
Medications Jun 06, 2012 | not rated yet | 0
European Union regulators have given Swiss pharmaceutical group Novartis a green light to market its drug Signifor as a treatment for Cushing's disease, the company said Wednesday.
Medications Apr 25, 2012 | 5 / 5 (1) | 0
(AP) -- Drug maker Novartis says it is taking legal action in Britain to make hospitals use an eye drug that costs 700 pounds ($1,130) per shot instead of a cheaper one that costs 60 pounds ($97).
Medications Apr 24, 2012 | 1 / 5 (1) | 0
(Medical Xpress) -- A research team from drug maker Novartis has discovered a compound that spurs cartilage growth in mice. As they describe in their paper published in the journal Science, the team has found that when a ...
Medical research Apr 06, 2012 | 5 / 5 (5) | 0 |
Swiss pharmaceutical group Novartis said Monday the European Union will allow it to expand its use of the drug Glivec to treat certain rare forms of gastrointestinal cancer.
Medications Feb 27, 2012 | not rated yet | 0
One hundred million treatments of Coartem Dispersible (artemether-lumefantrine), an antimalarial developed especially for children with Plasmodium falciparum malaria, have been delivered by Novartis to 39 malaria-endemic ...
Diseases, Conditions, Syndromes Feb 22, 2012 | 5 / 5 (1) | 0
(Medical Xpress) -- A University of Alberta researcher and Canada Excellence Research Chair in Virology has made the discovery of a vaccine that will potentially help combat hepatitis C. Michael Houghton, ...
Diseases, Conditions, Syndromes Feb 16, 2012 | 5 / 5 (17) | 0 |
Key players in the pharmaceutical industry pledged on Monday to donate 14 billion drug treatments as part of a new, global push to eradicate tropical diseases.
Diseases, Conditions, Syndromes Jan 30, 2012 | not rated yet | 0